Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★
- 1 November 1999
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 104 (5), 969-977
- https://doi.org/10.1016/s0091-6749(99)70077-1